118 related articles for article (PubMed ID: 71338)
21. Multiple sclerosis and cell-mediated hypersensitivity to myelin A1 protein.
Sheremata W; Cosgrove JB; Eylar EH
J Neurol Sci; 1976 Apr; 27(4):413-25. PubMed ID: 772176
[TBL] [Abstract][Full Text] [Related]
22. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis.
Greer JM; Csurhes PA; Cameron KD; McCombe PA; Good MF; Pender MP
Brain; 1997 Aug; 120 ( Pt 8)():1447-60. PubMed ID: 9278634
[TBL] [Abstract][Full Text] [Related]
23. Immunological studies of the pathogenesis of multiple sclerosis. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
Frick E
Acta Neurol Scand; 1989 Jan; 79(1):1-11. PubMed ID: 2467501
[TBL] [Abstract][Full Text] [Related]
24. Hyperreactivity to myelin basic protein in multiple sclerosis.
Eggers AE; Tarmin L; Plank CR; Gamboa ET
J Neurol Sci; 1981; 52(2-3):385-90. PubMed ID: 6171620
[TBL] [Abstract][Full Text] [Related]
25. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA
J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866
[TBL] [Abstract][Full Text] [Related]
26. Detection of human contact sensitivity to dinitrochlorobenzene by the migration inhibiton test.
Nishioka K
J Invest Dermatol; 1976 Jun; 66(6):351-4. PubMed ID: 778281
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of active E-rosette forming lymphocytes by myelin basic protein and specific antigens from multiple sclerosis brains.
Offner H; Rastogi SC; Konat G; Clausen J
J Neurol Sci; 1979 Aug; 42(3):349-55. PubMed ID: 92529
[TBL] [Abstract][Full Text] [Related]
28. Response of rat encephalitogenic T cells to synthetic peptides of guinea pig myelin basic protein.
Vandenbark AA; Hashim G; Offner H
Ann N Y Acad Sci; 1988; 540():337-9. PubMed ID: 2462807
[No Abstract] [Full Text] [Related]
29. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.
Nelson RD; Leu RW
J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355
[TBL] [Abstract][Full Text] [Related]
30. Effects of vaccination with T cell receptor peptides: epitope switching to a possible disease-protective determinant of myelin basic protein that is cross-reactive with a TCR BV peptide.
Vandenbark AA; Chou YK; Whitham R; Bourdette DN; Offner H
Immunol Cell Biol; 1998 Feb; 76(1):83-90. PubMed ID: 9553780
[TBL] [Abstract][Full Text] [Related]
31. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
Postlethwaite AE; Kang AH
J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
[TBL] [Abstract][Full Text] [Related]
32. Cell-mediated hypersensitivity in multiple sclerosis and other neurological diseases.
Minderhoud JM; Mourik J; Teelken AW
Clin Neurol Neurosurg; 1977; 80(1):22-32. PubMed ID: 73438
[TBL] [Abstract][Full Text] [Related]
33. A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide.
Wucherpfennig KW; Hafler DA
Ann N Y Acad Sci; 1995 Jul; 756():241-58. PubMed ID: 7544075
[TBL] [Abstract][Full Text] [Related]
34. Cell-mediated immune response to copolymer I in multiple sclerosis measured by the macrophage procoagulant activity assay.
Grgacic E; Bernard CC
Int Immunol; 1990; 2(8):713-8. PubMed ID: 1707304
[TBL] [Abstract][Full Text] [Related]
35. Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells.
Zang YC; Hong J; Rivera VM; Killian J; Zhang JZ
Int Immunol; 2003 Sep; 15(9):1073-80. PubMed ID: 12917259
[TBL] [Abstract][Full Text] [Related]
36. Effect of encephalitogenic protein on migration in agarose of leukocytes from patients with multiple sclerosis. Variable effect of the antigen in a large dose range, with a literature review.
Källén B; Nilsson O; Thelin C
Acta Neurol Scand; 1977 Jan; 55(1):33-46. PubMed ID: 65893
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of T-cell receptor alpha-chain complementarity-determining region 3 in myelin basic protein-specific T cells increases with severity of multiple sclerosis.
Utz U; Brooks JA; McFarland HF; Martin R; Biddison WE
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5567-71. PubMed ID: 7515505
[TBL] [Abstract][Full Text] [Related]
38. Aspects of cellular immunity in multiple sclerosis. Antigen-reactivity of lymphocytes and lymphokine activity.
Meyer-Rienecker HJ; Jenssen HL; Werner H
J Neurol Sci; 1979 Jul; 42(2):173-86. PubMed ID: 90125
[TBL] [Abstract][Full Text] [Related]
39. Age-related reactivity of lymphocytes from multiple sclerosis patients to myelin basic protein.
Wicher V; Olszewski W; Milgrom F
Int Arch Allergy Appl Immunol; 1981; 66(2):136-41. PubMed ID: 6169648
[TBL] [Abstract][Full Text] [Related]
40. Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS.
Arneth B
J Transl Med; 2015 Nov; 13():341. PubMed ID: 26526848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
